Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Keywords
(4)
Adipose Tissue
Adverse Effect
Macrophage Activation
Prussian Blue
Subscribe
Academic
Publications
BAS/BSCR24 Spironolactone reverses the adverse effects of aldosterone and hypoxia on adipose tissue
BAS/BSCR24 Spironolactone reverses the adverse effects of aldosterone and hypoxia on adipose tissue,10.1136/hrt.2010.205781.35,Heart,S. Withers,C. Aga
Edit
BAS/BSCR24 Spironolactone reverses the adverse effects of aldosterone and hypoxia on adipose tissue
BibTex
|
RIS
|
RefWorks
Download
S. Withers
,
C. Agabiti-Rosei
,
D. M. Livingstone
,
R. Aslam
,
R. A. Malik
,
A. M. Heagerty
We tested the hypothesis that aldosterone causes a loss of the normal anticontractile function of healthy fat via a hypoxia-related pathway, which can be rescued using spironolactone. Healthy rat mesenteric arteries (∼250%μM diameter) and perivascular fat were investigated using wire myography and Perl's
Prussian blue
staining for activated macrophages. The effects of aldosterone%±spironolactone were assessed after incubation for 10 min and 3 h, and experimental hypoxia (95% N2/5% CO2) for 2.5 h. Contractile responses were calculated as a percentage of KCl contraction and expressed as mean±SEM.
Macrophage activation
was expressed semiquantitatively and expressed as macrophage abundance values (MAV). The anticontractile capacity of healthy fat was lost upon incubation with aldosterone (5 nM) (fat: 90±4% n=36, fat+10 min aldosterone: 165±5% n=25, fat+3 h aldosterone 172%±12% n=7) and was associated with an increase in activated macrophages (immediately fixed: 2.2±0.5% n=5 vs 10 min aldosterone: 3.8±0.4% n=5, p=NS; immediately fixed: 2.2±0.5% n=5 vs 3 h aldosterone: 4.7±0.3% n=5, p=0.0313). Spironolactone (10%μM) restored anticontractile activity after incubation for 3 h only (3 h:111±4% p<0.05, n=5) and caused a significant reduction in
macrophage activation
(3.0±1.0%, n=5). As for aldosterone, hypoxia caused an increase in contractility (149±17% n=15) and
macrophage activation
(5.5±0.5% n=5), which was reversed upon incubation with spironolactone (contractility: 120±12% n=5;MAV: 3.3±0.8%, n=3, p=0.500). Aldosterone ameliorates the anticontractile capacity of healthy fat by a common pathway to hypoxia, which correlates with an increase in the number of activated macrophages within adipose tissue. Spironolactone can restore the effect of hypoxia on contractility and
macrophage activation
in the absence of aldosterone.
Journal:
Heart
, vol. 96, no. 17, pp. e19-e19, 2010
DOI:
10.1136/hrt.2010.205781.35
Cumulative
Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
(
dx.doi.org
)
(
heart.bmj.com
)